Mutual Recognition Agreement
MRA
What a definition is not
A definition is SPEQ’s plain-language decode of how a term is used in practice, cited to the documents that define it. It is a practitioner reference, not legal or regulatory advice, it does not replace the definition in the source, and where a regulator’s wording differs the regulator’s wording governs.
A mutual recognition agreement is a government-to-government arrangement under which authorities agree to recognize each other's GMP inspections and, where covered, batch certification — so that an inspection conducted by one party can be relied upon by the other instead of duplicating it. MRAs reduce redundant inspections, ease supply, and let each authority focus resources on higher-risk sites. Their scope is defined product-by-product and capability-by-capability, and depends on each side assessing the other's regulatory system as equivalent.
MRAs are not blanket: an operational MRA specifies which product types and activities are in scope, and recognition can be phased in as each party confirms the other's inspectorate meets an equivalent standard. Coverage of areas such as veterinary products or certain sterile processes may be added over time or excluded.
The EU–US MRA on pharmaceutical GMP inspections is the most cited example; the EU also operates MRAs and equivalent arrangements with several other countries.
- —Authorities recognize each other's GMP inspections (and sometimes batch testing)
- —Reduces duplicate inspections and refocuses resources on higher risk
- —Scope is product- and capability-specific, phased on equivalence
- —EU–US MRA is the flagship example
EU–US Mutual Recognition Agreement, pharmaceutical GMP sectoral annex; comparable EU MRAs with other countries.
Frequently asked questions
What does Mutual Recognition Agreement stand for?
Mutual Recognition Agreement stands for MRA.
What is Mutual Recognition Agreement?
A mutual recognition agreement is a government-to-government arrangement under which authorities agree to recognize each other's GMP inspections and, where covered, batch certification — so that an inspection conducted by one party can be relied upon by the other instead of duplicating it. MRAs reduce redundant inspections, ease supply, and let each authority focus resources on higher-risk sites. Their scope is defined product-by-product and capability-by-capability, and depends on each side assessing the other's regulatory system as equivalent.
Which regulations cover Mutual Recognition Agreement?
EU–US Mutual Recognition Agreement, pharmaceutical GMP sectoral annex; comparable EU MRAs with other countries.